IMPROVE-CKD Study: Impact of a phosphate binder on cardiovascular disease in Chronic Kidney Disease.

慢性肾脏病（CKD）是一种严重的健康问题，与心血管（CV）疾病的风险增加有关。血管钙化和动脉硬化（血管和动脉硬化）在CKD患者中非常常见，并且与CV事件的死亡增加有关。本研究旨在研究磷酸盐结合剂碳酸镧治疗可减少血管钙化和动脉僵硬以减少CV事件的方式。

Chronic kidney disease (CKD) is a significant health problem and is associated with an increased risk of cardiovascular (CV) disease. Vascular calcification and arterial stiffness (stiffening of the blood vessels and arteries) are very common in people with CKD, and are linked to increased death from CV events. This study aims to examine the ways in which treatment with a phosphate binder, Lanthanum Carbonate, may reduce vascular calcification and arterial stiffness to decrease CV events.